A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin
Status:
Completed
Trial end date:
2012-02-03
Target enrollment:
Participant gender:
Summary
In this study the effect of ipragliflozin on glucose homeostasis in healthy subjects and T2DM
subjects, and the effect of exposure of ipragliflozin on urinary glucose excretion and plasma
glucose in T2DM subjects will be investigated.